The Association for the Advancement of Medical Instrumentation (AAMI) is reporting that the Food and Drug Administration (FDA)’s Center for Devices and Radiological Health (CDRH) has released a final implementation plan that details actions the agency intends to take to improve the efficiency and review times of medical device submissions.
In an update to a plan released in June, the CDRH details what actions it will take in response to 11 recommendations made by Booz Allen Hamilton (BAH), an independent contractor, in a June 2014 report. The recommendations are the following:
• Adopt a holistic, multipronged approach to address five quality component areas to standardize process lifecycle management activities and improve consistency of reviews.
• Develop criteria and establish mechanisms to improve consistency in decision making throughout the review process.
• Optimize the refuse-to-accept process by improving awareness of and clarity around the administrative requirements for 510(k) submissions.
• Perform a retrospective root cause analysis of withdrawn submissions and develop a mechanism to minimize their occurrence.
• Implement a consistent practice for communicating early and frequently with sponsors during the substantive review phase to address and resolve potential issues prior to substantive interaction.
• Provide mandatory full-staff training for the three primary information technology systems that support Medical Device User Fee Amendments of 2012 (MDUFA III) reviews.
• Provide increased clarity to applicants beyond existing eCopy guidance to enhance organized submission structure.
• Evaluate tools for providing a comprehensive view of staff workload.
• Identify metrics and incorporate methods to better assess review process training satisfaction, learning, and staff behavior changes.
• Promote informal training and knowledge sharing by seasoned staff for review staff and management to share division- or science-specific review processes, lessons learned, and best practices.
• Develop CDRH-wide staff transition and succession plans to mitigate the impact of turnover on submission reviews.
To read further from AAMI, CLICK HERE.
Source: AAMI
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.